Optimal Dosage Justification for Datopotamab Deruxtecan in HR ‐Positive/ HER2 ‐Negative Breast Cancer Through Model‐Informed Drug Development Approaches

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Zoey Tang, KyoungSoo Lim, Yu Jiang, David Dai, Manjunatha Munegowda, Sabrina Khan, Lu Xu, Lei Shi, Yuzhuo Pan, Ying Hong, Song Ren, Pavan Vajjah, Megan Gibbs, Diansong Zhou
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Clinical and Translational Science
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet